Literature DB >> 32679351

Effective omalizumab interval prolongation in the treatment of chronic urticaria.

Mehran Alizadeh Aghdam1, Rianne Henriëtte Pieterse2, Petra Adriana Kentie2, Feiko Rijken2, André Cornelis Knulst2, Heike Röckmann2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32679351     DOI： 10.1016/j.jaip.2020.06.056

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  1 in total

1.  Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.

Authors:  Maria Maddalena Sirufo; Enrica Maria Bassino; Francesca De Pietro; Lia Ginaldi; Massimo De Martinis
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.